22:50:58 EDT Thu 20 Aug 2026
Enter Symbol
or Name
USA
CA



FLOWERS FOODS, INC. REPORTS SECOND QUARTER 2026 RESULTS

2026-08-20 16:05 ET - News Release

FLOWERS FOODS, INC. REPORTS SECOND QUARTER 2026 RESULTS

PR Newswire

THOMASVILLE, Ga., Aug. 20, 2026 /PRNewswire/ -- Flowers Foods, Inc. (NYSE: FLO) today reported financial results for the company's 12-week second quarter ended July 18, 2026.

Second Quarter Summary:
Compared to the prior year second quarter where applicable

  • Net sales(1) decreased 4.0% to $1.193 billion as favorable price/mix was more than offset by lower volume.
  • Net income decreased 30.3% to $40.7 million, representing 3.4% of sales, a 130-basis point decrease, primarily due to a challenging consumer environment, increased marketing expense, and increases in labor and freight costs, partly offset by lower interest expense and moderating ingredient costs. Adjusted net income(2) decreased 30.5% to $44.1 million.
  • Adjusted EBITDA(2) decreased 19.2% to $111.3 million, representing 9.3% of net sales, a 180-basis point decrease.
  • Diluted EPS decreased $0.09 to $0.19. Adjusted diluted EPS(2) decreased $0.09 to $0.21.

Chairman and CEO Remarks:
"Our second quarter results reflect the continued challenges across the fresh packaged bread category, where macroeconomic pressures, evolving consumer purchasing behavior, and sustained competitive activity created a more difficult operating environment than we anticipated," said Ryals McMullian, chairman and CEO of Flowers Foods. "While these headwinds weighed on our performance, they also reinforced the actions we are taking to strengthen our competitiveness and improve execution.

"Against this backdrop, we are accelerating initiatives already underway to improve our performance and better align our resources with the opportunities that we believe will create the greatest long-term value. That includes sharpening our value proposition, improving in-store execution, accelerating innovation, winning new business opportunities, and continuing to invest behind our leading brands.

"The relaunch of Nature's Own is an important example of that strategy in action. Early feedback from customers and distribution partners has been excellent, particularly around the brand's simpler ingredients, stronger better-for-you positioning, and Non-GMO Project Verified offering at national scale. While this initiative remains in its early stages and has not yet meaningfully contributed to results, positive customer feedback and the brand's growing presence in the better-for-you segment reinforce our confidence in Nature's Own's ability to extend its category leadership over time.

"In addition, consistent with the findings in our comprehensive review, we are taking select actions to further realign our organization and improve our cost structure. These actions are intended to simplify our operations, improve execution, and better position the company to respond to evolving consumer needs.

"Given our first-half performance and the current category environment, we are updating our full-year outlook to reflect a more cautious view for the balance of 2026. While near-term conditions remain challenging, we are confident that the actions underway will strengthen our top-line trajectory and better position our portfolio to meet evolving consumer demand."

Revised Outlook: 52-week Fiscal 2026, the Company Expects:

  • Net sales of approximately $5.070 billion to $5.142 billion, representing a -3.5% to -2.2% change compared to the prior year. Prior guidance called for net sales of approximately $5.163 billion to $5.267 billion.
  • Adjusted EBITDA(3) in the range of approximately $453 million to $481 million, compared to prior guidance of $465 million to $495 million.
  • Adjusted diluted EPS(2) of approximately $0.75 to $0.85 per share, compared to prior guidance of $0.80 to $0.90 per share.

The company's outlook is based on the following assumptions:

  • Depreciation and amortization of approximately $165 million to $170 million.
  • Net interest expense of approximately $65 million to $70 million.
  • An effective tax rate of approximately 26%.
  • Weighted average diluted share count for the year of approximately 213.5 million shares.
  • Capital expenditures of approximately $115 million to $125 million.

Matters Affecting Comparability:

                            
        
          
            Reconciliation of Earnings per Share to Adjusted Earnings per Share

                                                                            ---



                                                                                                                            For the 12-Week          For the 12-Week
                                                                                                                       Period Ended         Period Ended


                                                                                                                            July 18, 2026          July 12, 2025



      Net income per diluted common share                                                                                 $
        0.19          $
        0.28



      Business process improvement costs                                                                                   
        NM          
        NM



      Restructuring-related implementation costs                                                                                    0.02                    0.01



      Acquisition and integration-related costs                                                                                                            0.01     (a)



      Legal settlements and related costs                                                                                                         
        NM



      Recovery on inferior ingredients                                                                                            (0.01)



      Adjusted net income per diluted common share                                                                        $
        0.21          $
        0.30





      (a) Deductible tax impact of prior period acquisition-related costs that impacted this period by $0.01 per
share.


          
            NM - not meaningful.


          
            Certain amounts may not add due to rounding.

Consolidated Second Quarter Operating Highlights
Compared to the prior year second quarter where applicable

  • Net sales decreased 4.0% to $1.193 billion. Pricing/mix(4) increased 1.8% and volume(5) declined 5.8%.
  • Branded Retail net sales decreased $31.7 million, or 3.8%, to $794.6 million due to volume declines partially offset by favorable pricing/mix. Pricing/mix(4) rose 3.8%, volume(5) decreased 7.6%.
  • Other net sales decreased $18.2 million, or 4.4%, to $398.3 million due to inflationary pressure on consumer spending impacting store branded sales. Pricing/mix(4) decreased 1.0% and volume(5) declined 3.4%.
  • Materials, supplies, labor, and other production costs (exclusive of depreciation and amortization) were 51.6% of net sales, a 40-basis point increase. These costs increased as a percentage of net sales mostly due to lower production volumes and an increase in labor costs and outside purchases of product (sales with no associated ingredient costs). This increase was partially offset by moderating ingredient costs.
  • Selling, distribution, and administrative (SD&A) expenses were 39.7% of net sales, a 160-basis point increase. SD&A expenses increased as a percentage of net sales due to higher workforce-related and freight costs and increased marketing spend, partially offset by lower distributor distribution fees. Excluding matters affecting comparability, adjusted SD&A(2) was 39.1% of net sales, a 140-basis point increase.
  • Depreciation and amortization (D&A) expenses were $38.6 million or 3.2% of net sales, flat with last year's second quarter.
  • Net interest expense decreased $1.3 million primarily due to lower debt balances.
  • Net income decreased 30.3% to $40.7 million, representing 3.4% of sales, a 130-basis point decrease, and diluted EPS decreased $0.09 to $0.19. Adjusted net income(2) decreased 30.5% to $44.1 million and adjusted diluted EPS(2) decreased $0.09 to $0.21.
  • Adjusted EBITDA(2) decreased 19.2% to $111.3 million, representing 9.3% of net sales, a 180-basis point decrease.

Cash Flow, Capital Allocation, and Capital Return
Year-to-date, cash flow from operating activities decreased $24.9 million to $241.5 million, capital expenditures decreased $11.9 million to $44.5 million, and dividends paid to shareholders decreased $23.7 million to $81.0 million. Cash and cash equivalents were $52.8 million at quarter end.

(1) Any reference to sales refers to net sales inclusive of allowances and deductions against gross sales for variable consideration and consideration payable to customers
(2) Adjusted for items affecting comparability. See reconciliations of non-GAAP measures in the financial statements following this release. Earnings are net income. EBITDA and Adjusted EBITDA are reconciled to net income.
(3) No reconciliation of the forecasted range for adjusted EBITDA to net income for the 52-week Fiscal 2026 is included in this press release because the company is unable to quantify certain amounts that would be required to be included in the GAAP measure without unreasonable efforts. In addition, the company believes such reconciliation would imply a degree of precision that would be confusing or misleading to investors. For the same reasons, the company is unable to address the probable significance of the unavailable information, which could be material to future results.
(4) Calculated as (current year period units X change in price per unit) / prior year period net sales dollars
(5) Calculated as (prior year period price per unit X change in units) / prior year period net sales dollars

Pre-Recorded Management Remarks and Question and Answer Webcast
In conjunction with this release, Flowers Foods will post pre-recorded management remarks and a supporting slide presentation on the investors page of flowersfoods.com. The company will host a live question and answer webcast at 8:30 a.m. Eastern Time on August 21, 2026, which will be archived on the investors page along with the other related materials.

About Flowers Foods
Headquartered in Thomasville, Ga., Flowers Foods, Inc. (NYSE: FLO) is one of the largest producers of packaged bakery foods in the United States with 2025 net sales of $5.3 billion. Flowers operates bakeries across the country that produce a wide range of bakery products. Among the company's top brands are Nature's Own, Dave's Killer Bread, Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. Learn more at www.flowersfoods.com.

FLO-CORP FLO-IR

Forward-Looking Statements
Statements contained in this press release and certain other written or oral statements made from time to time by Flowers Foods, Inc. (the "company", "Flowers Foods", "Flowers", "us", "we", or "our") and its representatives that are not historical facts are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to current expectations regarding our business and our future financial condition and results of operations and are often identified by the use of words and phrases such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," "will," "would," "is likely to," "is expected to" or "will continue," or the negative of these terms or other comparable terminology. These forward-looking statements are based upon assumptions we believe are reasonable. Forward-looking statements are based on current information and are subject to risks and uncertainties that could cause our actual results to differ materially from those projected. Certain factors that may cause actual results, performance, liquidity, and achievements to differ materially from those projected are discussed in our Annual Report on Form 10-K for the year ended January 3, 2026 (the "Form 10-K") and our Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission ("SEC") and may include, but are not limited to, (a) unexpected changes in any of the following: (1) general economic and business conditions; (2) the competitive setting in which we operate, including advertising or promotional strategies by us or our competitors, as well as changes in consumer demand; (3) interest rates and other terms available to us on our borrowings; (4) supply chain conditions and any related impact on energy and raw materials costs and availability and hedging counter-party risks; (5) relationships with or increased costs related to our employees and third-party service providers; (6) laws and regulations (including environmental and health-related issues and the impacts of tariffs, including retaliatory tariffs); and (7) accounting standards or tax rates in the markets in which we operate, (b) the loss or financial instability of any significant customer(s), including as a result of product recalls or safety concerns related to our products, (c) changes in consumer behavior, trends and preferences, including health and whole grain trends and consumer buying habits, the movement toward less expensive store branded products, and the continued reduction of purchases in the fresh packaged bread category, (d) the level of success we achieve in developing and introducing new products and entering new markets, (e) our ability to implement new technology and customer requirements as required, (f) our ability to operate existing, and any new, manufacturing lines according to schedule, (g) our ability to implement and achieve our corporate responsibility goals in accordance with regulatory requirements and the expectations of our stakeholders, suppliers, and customers; (h) our ability to execute our business strategies which may involve, among other things, (1) the ability to realize the intended benefits of completed, planned or contemplated acquisitions, dispositions or joint ventures, such as the acquisition of Simple Mills, (2) the deployment of new systems (e.g., our enterprise resource planning ("ERP") system), distribution channels and technology, and (3) an enhanced organizational structure (e.g., our sales and supply chain reorganization), (i) consolidation within the baking industry and related industries, (j) changes in pricing, customer and consumer reaction to pricing actions (including decreased volumes), and the pricing environment among competitors within the industry, (k) our ability to adjust pricing to offset, or partially offset, inflationary pressure or tariffs (including retaliatory tariffs) on the cost of our products, including ingredient and packaging costs; (l) disruptions in our direct-store-delivery distribution model, including litigation or an adverse ruling by a court or regulatory or governmental body that could affect the independent contractor classifications of the independent distributor partners ("IDPs"), and changes to our direct-store-delivery distribution model in California, (m) increasing legal complexity and legal proceedings that we are or may become subject to, (n) labor shortages and turnover or increases in employee and employee-related costs, (o) the credit, business, and legal risks associated with IDPs and customers, which operate in the highly competitive retail food and foodservice industries, (p) any business disruptions due to political instability, pandemics, armed hostilities, incidents of terrorism, natural disasters, labor strikes or work stoppages, technological breakdowns, product contamination, product recalls or safety concerns related to our products, or the responses to or repercussions from any of these or similar events or conditions and our ability to insure against such events, (q) the failure of our information technology systems to perform adequately, including any interruptions, intrusions, cyber-attacks or security breaches of such systems or risks associated with the implementation of the upgrade of our ERP system; and (r) the potential impact of climate change on the company, including physical and transition risks, our availability or restriction of resources, higher regulatory and compliance costs, reputational risks, and our availability of capital on attractive terms. The foregoing list of important factors does not include all such factors, nor does it necessarily present them in order of importance. In addition, you should consult other disclosures made by the company (such as in our other filings with the SEC or in company press releases) for other factors that may cause actual results to differ materially from those projected by the company. Refer to Part I, Item 1A., Risk Factors, of our Form 10-K, Part II, Item 1A., Risk Factors, of the Form 10-Q for the quarter ended July 18, 2026 and subsequent filings with the SEC for additional information regarding factors that could affect the company's results of operations, financial condition and liquidity. We caution you not to place undue reliance on forward-looking statements, as they speak only as of the date made and are inherently uncertain. The company undertakes no obligation to publicly revise or update such statements, except as required by law. You are advised, however, to consult any further public disclosures by the company (such as in our filings with the SEC or in company press releases) on related subjects.

Information Regarding Non-GAAP Financial Measures
The company prepares its consolidated financial statements in accordance with U.S. Generally Accepted Accounting Principles (GAAP). However, from time to time, the company may present in its public statements, press releases and SEC filings, non-GAAP financial measures such as, EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted diluted EPS, adjusted income tax expense, adjusted selling, distribution and administrative expenses (SD&A), and gross margin excluding depreciation and amortization. The reconciliations attached provide reconciliations of the non-GAAP measures used in this presentation or release to the most comparable GAAP financial measure. The company's definitions of these non-GAAP measures may differ from similarly titled measures used by others. These non-GAAP measures should be considered supplemental to, and not a substitute for, financial information prepared in accordance with GAAP.

The company defines EBITDA as earnings before interest, taxes, depreciation and amortization. Earnings are net income. The company believes that EBITDA is a useful tool for managing the operations of its business and is an indicator of the company's ability to incur and service indebtedness and generate free cash flow. The company also believes that EBITDA measures are commonly reported and widely used by investors and other interested parties as measures of a company's operating performance and debt servicing ability because EBITDA measures assist in comparing performance on a consistent basis without regard to depreciation or amortization, which can vary significantly depending upon accounting methods and non-operating factors (such as historical cost). EBITDA is also a widely-accepted financial indicator of a company's ability to incur and service indebtedness.

EBITDA should not be considered an alternative to (a) income from operations or net income (loss) as a measure of operating performance; (b) cash flows provided by operating, investing and financing activities (as determined in accordance with GAAP) as a measure of the company's ability to meet its cash needs; or (c) any other indicator of performance or liquidity that has been determined in accordance with GAAP.

The company defines adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted diluted EPS, adjusted income tax expense and adjusted SD&A, respectively, to exclude additional costs that the company considers important to present to investors to increase the investors' insights about the company's core operations. These costs include, but are not limited to, the costs of closing a plant or costs associated with acquisition and integration-related activities, restructuring activities, certain impairment charges, legal settlements, costs to implement an enterprise resource planning system and enhance bakery digital capabilities (business process improvement costs) to provide investors direct insight into these costs, and other costs impacting past and future comparability. The company believes that these measures, when considered together with its GAAP financial results, provide management and investors with a more complete understanding of its business operating results, including underlying trends, by excluding the effects of certain charges. Adjusted EBITDA is used as a performance measure in the company's incentive compensation program.

Presentation of gross margin includes depreciation and amortization in the materials, supplies, labor and other production costs according to GAAP. Our method of presenting gross margin excludes the depreciation and amortization components, as discussed above.

The reconciliations attached provide reconciliations of the non-GAAP measures used in this release to the most comparable GAAP financial measure.


   
            Flowers Foods, Inc.


   
            Condensed Consolidated Balance Sheets



   (000's omitted)




                                                                                     July 18,          January 3,
                                                                                       2026                2026



   
            
              Assets

---


   Cash and cash equivalents                                                $
    
       52,766    $
          12,100



   Other current assets                                                                  712,002               694,753



   Property, plant and equipment, net                                                    926,854               952,725



   Right-of-use leases, net                                                              309,305               321,116



   Distributor notes receivable (1)                                                      129,910               130,723



   Other assets                                                                           42,410                40,007



   Cost in excess of net tangible assets, net                                          2,012,595             2,032,437



   Total assets                                                          $
    
       4,185,842 $
          4,183,861


                                Liabilities and Stockholders' Equity

---


   Current liabilities                                                     $
    
       543,163   $
          502,804



   Long-term debt (2)                                                                  1,686,246             1,755,132



   Right-of-use lease liabilities (3)                                                    317,102               325,075



   Other liabilities                                                                     315,830               297,363



   Stockholders' equity                                                                1,323,501             1,303,487



   Total liabilities and stockholders' equity                            $
    
       4,185,842 $
          4,183,861





   (1)  Includes current portion of $21,577 and $22,241, respectively.



   (2)  Includes current portion of $399,885 and $399,575, respectively.



   (3)  Includes current portion of $75,162 and $73,778, respectively.


         
            Flowers Foods, Inc.


         
            Consolidated Statement of Operations



         (000's omitted, except per share data)




                                                                                                For the 12-Week           For the                         For the                    For the
                                                                                                                           12-Week                         28-Week                    28-Week
                                                                                     Period Ended                Period Ended             Period Ended                      Period Ended


                                                                                                July 18, 2026        July 12, 2025                   July 18, 2026              July 12, 2025



         Net sales                                                           $
          
            1,192,935   $
          1,242,835 $
          
            2,764,512         $
        2,797,065



         Materials, supplies, labor and other production costs (exclusive of                            615,005                 636,060                          1,410,394                   1,414,406
  depreciation and amortization shown separately below)



         Selling, distribution, and administrative expenses                                             473,185                 473,537                          1,116,119                   1,107,050



         Restructuring charges                                                                                                                                     1,652                         573



         Plant closure costs and impairment of assets                                                                                                                                         7,397



         Recovery on inferior ingredients                                                               (1,963)                                                  (1,963)



         Depreciation and amortization expense                                                           38,579                  39,826                             90,369                      89,094



         Income from operations                                                                          68,129                  93,412                            147,941                     178,545



         Other pension cost (benefit)                                                                        88                    (88)                               206                       (205)



         Interest expense, net                                                                           13,787                  15,036                             33,421                      29,084



         Income before income taxes                                                                      54,254                  78,464                            114,314                     149,666



         Income tax expense                                                                              13,598                  20,099                             31,603                      38,303



         Net income                                                             $
          
            40,656      $
          58,365    $
          
            82,711           $
        111,363



         Net income per diluted common share                                      $
          
            0.19        $
          0.28      $
          
            0.39              $
        0.53



         Diluted weighted average shares outstanding                                                    212,493                 211,991                            212,545                     212,084


         
            Flowers Foods, Inc.


         
            Condensed Consolidated Statement of Cash Flows


                                                                                 
 (000's omitted)




                                                                                                                 For the             For the                    For the 28-Week                 For the
                                                                                                                  12-Week             12-Week                                                 28-Week
                                                                                                   Period Ended              Period Ended           Period Ended                    Period Ended


                                                                                                               July 18, 2026         July 12, 2025                  July 18, 2026              July 12, 2025



         
            Cash flows from operating activities:



         Net income                                                                         $
          
            40,656     $
          58,365 $
          
            82,711          $
          111,363



         Adjustments to reconcile net income to net cash from operating
  activities:



            Total non-cash adjustments                                                                               53,018                 74,705                         139,506                      151,840



            Changes in assets and liabilities                                                                        40,014                (2,241)                         19,328                        3,260



         
            Net cash provided by operating activities                                                     133,688                130,829                         241,545                      266,463



         
            Cash flows from investing activities:



            Purchase of property, plant and equipment                                                              (23,853)              (30,810)                       (44,476)                    (56,366)



            Acquisition of business, net of cash acquired                                                                                                                                          (791,880)



            Other                                                                                                   (1,274)               (4,563)                          (284)                    (23,141)



         
            Net cash disbursed for investing activities                                                  (25,127)              (35,373)                       (44,760)                   (871,387)



         
            Cash flows from financing activities:



            Dividends paid                                                                                         (26,594)              (52,449)                       (81,024)                   (104,772)



            Stock repurchases                                                                                          (37)                                              (3,824)                     (5,499)



            Net change in debt borrowings                                                                          (38,000)              (41,700)                       (70,000)                     734,880



            Payment of financing fees                                                                                 (289)                  (64)                        (2,056)                    (10,120)



            Other                                                                                                   (2,394)                 2,462                             785                      (3,525)



         
            Net cash (disbursed for) provided by financing activities                                    (67,314)              (91,751)                      (156,119)                     610,964



         Net increase in cash and cash equivalents                                                                   41,247                  3,705                          40,666                        6,040



         Cash and cash equivalents at beginning of period                                                            11,519                  7,340                          12,100                        5,005



         Cash and cash equivalents at end of period                                         $
          
            52,766     $
          11,045 $
          
            52,766           $
          11,045

                                                         
     
            Flowers Foods, Inc.

                                                   
   
       Net Sales by Sales Class and Net Sales Bridge


                                                           
     
            (000's omitted)




                              Net Sales by Sales Class




                                                                      For the 12-Week                      For the 12-Week
                                                                           Period                               Period
                                                                Ended                                      Ended


                                                                       July 18, 2026                        July 12, 2025                
     $ Change                % Change



 Branded Retail                                            $
     
            794,642                     $
          826,364            $
          (31,722)                 (3.8)
                                                                                                                                                                                  %



 Other                                                                         398,293                                 416,471                        (18,178)                 (4.4)
                                                                                                                                                                                  %



 
            Total Net Sales                            $
     
            1,192,935                   $
          1,242,835            $
          (49,900)                 (4.0)
                                                                                                                                                                                  %




                                                                                     For the 28-Week                      For the 28-Week
                                                                                      Period                           Period
                                                                Ended                                      Ended


                                                                                     July 18, 2026                       July 12, 2025             
          $ Change              % Change



 Branded Retail                                          $
     
            1,839,860                   $
          1,837,551               $
          2,309                    0.1
                                                                                                                                                                                  %



 Other                                                                         924,652                                 959,514                        (34,862)                 (3.6)
                                                                                                                                                                                  %



 
            Total Net Sales                            $
     
            2,764,512                   $
          2,797,065            $
          (32,553)                 (1.2)
                                                                                                                                                                                  %


 
            
              Net Sales Bridge





 
            
              For the 12-week period ended July 18, 2026             Branded
                                                                                      Retail            Other Total



 Pricing/mix^*                                                                  3.8            (1.0)    1.8
                                                                                   %
                                                                                                   %      %



 Volume*                                                                      (7.6)           (3.4)  (5.8)
                                                                                   %
                                                                                                   %
                                                                                                          %


                                                                         (3.8)        (4.4)  (4.0)

                                                                                   %



 
            Total percentage point change in net sales                                          %      %




          
            
              For the 28-week period ended July 18, 2026                                                                                        Branded Retail        Other     Total



          Pricing/mix^*                                                                                                                                        3.9
   %                (1.0)
                                                                                                                                                                                                      %
                                                                                                                                                                                            %       1.9



          Volume*                                                                                                                                            (5.8)
   %                (2.6)     (4.4)

                                                                                                                                                                                            %         %



          Acquisition (until cycled on February 21, 2026)                                                                                                      2.0
   %                            1.3
                                                                                                                                                                                                      %



          
            Total percentage point change in net sales                                                                                                   0.1                 (3.6)     (1.2)
                                                                                                                                                                       %

                                                                                                                                                                                            %         %





          The table above presents certain sales by category that have been reclassified from amounts previously reported to conform to the current period
presentation.



          
            ^ Includes sales reductions from variable consideration and payments to customers.



          
            * Computations above are calculated as follows (the Total column is consolidated and is not adding the Branded Retail and Other columns):



                Price/Mix $ = Current year period units × change in price per unit



                Price/Mix % = Price/Mix $ ÷ Prior year period Net Sales $





                Volume $ = Prior year period price per unit × change in units



                Volume % = Volume $ ÷ Prior year period Net Sales $


          
            Flowers Foods, Inc.


          
            Reconciliation of GAAP to Non-GAAP Measures


                                                                                                      
          (000's omitted, except per share data)




                                                                                                                                                              Reconciliation of Earnings per Share to Adjusted Earnings per Share


                                                                                                                               For the 12-Week                        For the                                                  For the 28-Week                       For the
                                                                                                                                                                    12-Week                                                                                     28-Week
                                                                                                                  Period Ended                           Period Ended                                        Period Ended                          Period Ended


                                                                                                                               July 18, 2026                      July 12, 2025                                                July 18, 2026                     July 12, 2025



          Net income per diluted common share                                                                $
          
            0.19                    $
          0.28                                $
          
            0.39                   $
          0.53



          Business process improvement costs                                                                                          NM                    
          NM                                                        0.01                    
          NM



          Plant closure costs and impairment of assets                                                                                                                                                                                                                 0.03



          Restructuring charges                                                                                                                                                                                                      0.01                    
          NM



          Restructuring-related implementation costs                                                                                  0.02                                0.01                                                         0.05                               0.03



          Acquisition and integration-related costs                                                                                                                      0.01                   (a)                                   NM      (a)                     0.06



          Legal settlements and related costs                                                                                                                 
          NM                                                        0.05                    
          NM



          Recovery on inferior ingredients                                                                                          (0.01)                                                                                         (0.01)



          Adjusted net income per diluted common share                                                       $
          
            0.21                    $
          0.30                                $
          
            0.49                   $
          0.65



          
            NM - not meaningful.



          
            Certain amounts may not add due to rounding.



          (a) Includes the reclassification of costs between deductible and non-deductible for income tax purposes for certain acquisition-related costs from
the prior period.



                                                                                                            
 
            Reconciliation of Gross Margin


                                                                                           For the 12-Week              For the                                         For the                   For the
                                                                                                                          12-Week                                         28-Week                   28-Week
                                                                                 Period Ended                   Period Ended                             Period Ended                     Period Ended


                                                                                           July 18, 2026            July 12, 2025                                   July 18, 2026             July 12, 2025



         Net sales                                                        $
        
            1,192,935      $
          1,242,835                 $
          
            2,764,512        $
         2,797,065



         Materials, supplies, labor and other production costs (exclusive                          615,005                    636,060                                          1,410,394                   1,414,406
  of depreciation and amortization)



         Gross margin excluding depreciation and amortization                                      577,930                    606,775                                          1,354,118                   1,382,659



         Less depreciation and amortization for production activities                               21,910                     21,072                                             50,871                      48,555



         Gross margin                                                       $
        
            556,020        $
          585,703                 $
          
            1,303,247        $
         1,334,104



         Depreciation and amortization for production activities             $
        
            21,910         $
          21,072                    $
          
            50,871           $
         48,555



         Depreciation and amortization for selling, distribution, and                               16,669                     18,754                                             39,498                      40,539
  administrative activities



         Total depreciation and amortization                                 $
        
            38,579         $
          39,826                    $
          
            90,369           $
         89,094



                                                                                          Reconciliation of Selling, Distribution, and Administrative Expenses to
                                                                                                                        Adjusted SD&A


                                                                          For the 12-Week                 For the 12-Week                                   For the 28-Week             For the 28-Week
                                                               Period Ended                        Period Ended                              Period Ended                     Period Ended


                                                                          July 18, 2026                 July 12, 2025                                   July 18, 2026              July 12, 2025



        Selling, distribution, and administrative expenses $
       
            473,185             $
          473,537                  $
          
            1,116,119         $
          1,107,050
  (SD&A)



        Business process improvement costs                                       (1,010)                          (471)                                            (2,251)                      (1,362)



        Restructuring-related implementation costs                               (5,545)                        (2,896)                                           (13,772)                      (7,184)



        Acquisition and integration-related costs                                                                 (871)                                            (1,897)                     (14,635)



        Legal settlements and related costs                                                                       (205)                                           (14,400)                        (902)



        Adjusted SD&A                                      $
       
            466,630             $
          469,094                  $
          
            1,083,799         $
          1,082,967


 
            Flowers Foods, Inc.


 
            Reconciliation of GAAP to Non-GAAP Measures


                                                           
    (000's omitted, except per share data)




                                                                                                       Reconciliation of Net Income to EBITDA and Adjusted EBITDA


                                                                               For the 12-Week                    For the                                       For the 28-Week                 For the
                                                                                                                   12-Week                                                                        28-Week
                                                                    Period Ended                         Period Ended                               Period Ended                      Period Ended


                                                                               July 18, 2026                 July 12, 2025                                     July 18, 2026              July 12, 2025



 Net income                                                    $
          
            40,656               $
          58,365                      $
          
            82,711           $
          111,363



 Income tax expense                                                                     13,598                           20,099                                               31,603                        38,303



 Interest expense, net                                                                  13,787                           15,036                                               33,421                        29,084



 Depreciation and amortization                                                          38,579                           39,826                                               90,369                        89,094



 EBITDA                                                                                106,620                          133,326                                              238,104                       267,844



 Other pension cost (benefit)                                                               88                             (88)                                                 206                         (205)



 Business process improvement costs                                                      1,010                              471                                                2,251                         1,362



 Plant closure costs and impairment of assets                                                                                                                                                             7,397



 Restructuring charges                                                                                                                                                       1,652                           573



 Restructuring-related implementation costs                                              5,545                            2,896                                               13,772                         7,184



 Acquisition and integration-related costs                                                                                 871                                                1,897                        14,635



 Legal settlements and related costs                                                                                       205                                               14,400                           902



 Recovery on inferior ingredients                                                      (1,963)                                                                             (1,963)



 Adjusted EBITDA                                              $
          
            111,300              $
          137,681                     $
          
            270,319           $
          299,692



 Net sales                                                  $
          
            1,192,935            $
          1,242,835                   $
          
            2,764,512         $
          2,797,065



 Adjusted EBITDA margin                                                                    9.3                             11.1                                                  9.8
                                                                                                                              %                                                                                %
                                                                                              %                                                                                   %                         10.7



                                                                                                                                                                     Reconciliation of Income Tax Expense to Adjusted Income Tax Expense


                                                                                                                                 For the 12-Week                        For the 12-Week                                                 For the 28-Week                   For the 28-Week
                                                                                                                     Period Ended                               Period Ended                                          Period Ended                          Period Ended


                                                                                                                                 July 18, 2026                        July 12, 2025                                                 July 18, 2026                   July 12, 2025



 Income tax expense                                                                                            $
          
            13,598                     $
          20,099                                 $
          
            31,603                $
          38,303



 Tax impact of:



 Business process improvement costs                                                                                                        253                                    118                                                             563                               341



 Plant closure costs and impairment of assets                                                                                                                                                                                                                                  1,850



 Restructuring charges                                                                                                                                                                                                                          413                               144



 Restructuring-related implementation costs                                                                                              1,386                                    724                                                           3,443                             1,796



 Acquisition and integration-related costs                                                                                                                                   (1,510)                   (a)                                    2,214    (a)                      1,929



 Legal settlements and related costs                                                                                                                                              52                                                           3,600                               226



 Recovery on inferior ingredients                                                                                                        (491)                                                                                                (491)



 Adjusted income tax expense                                                                                   $
          
            14,746                     $
          19,483                                 $
          
            41,345                $
          44,589





 (a) Includes the reclassification of costs between deductible and non-deductible for income tax purposes for certain acquisition-related costs from the prior period.


          
            Flowers Foods, Inc.


          
            Reconciliation of GAAP to Non-GAAP Measures


                                                                                                         
          (000's omitted, except per share data)




                                                                                                                                              
          
            Reconciliation of Net Income to Adjusted Net Income


                                                                                                                           For the 12-Week                         For the
                                                                                                                                                                  12-Week                                                   For the 28-Week                  For the 28-Week
                                                                                                                Period Ended                            Period Ended                                          Period Ended                         Period Ended


                                                                                                                           July 18, 2026                      July 12, 2025                                                 July 18, 2026                  July 12, 2025



          Net income                                                                                     $
          
            40,656                   $
          58,365                                 $
          
            82,711              $
          111,363



          Business process improvement costs                                                                                         757                                  353                                                           1,688                            1,021



          Plant closure costs and impairment of assets                                                                                                                                                                                                                5,547



          Restructuring charges                                                                                                                                                                                                       1,239                              429



          Restructuring-related implementation costs                                                                               4,159                                2,172                                                          10,329                            5,388



          Impairment of intangible assets



          Acquisition and integration-related costs                                                                                                                    2,381                    (a)                                    (317)  (a)                     12,706



          Legal settlements and related costs                                                                                                                            153                                                          10,800                              676



          Recovery on inferior ingredients                                                                                       (1,472)                                                                                            (1,472)



          Adjusted net income                                                                            $
          
            44,100                   $
          63,424                                $
          
            104,978              $
          137,130





          (a) Includes the reclassification of costs between deductible and non-deductible for income tax purposes for certain acquisition-related costs from
the prior period.



                                                                              Reconciliation of Earnings per
                                                                                          Share -
                                                                        Full Year Fiscal 2026 Guidance


                                                                                      Range Estimate



 Net income per diluted common share                       $
 
   0.64                             to       $
 
    0.74



 Business process improvement costs                               0.01                                              0.01



 Restructuring charges                                            0.01                                              0.01



 Restructuring-related implementation costs                       0.05                                              0.05



 Acquisition and integration-related costs                        NM                                             NM



 Legal settlements and related costs                              0.05                                              0.05



 Recovery on inferior ingredients                               (0.01)                                           (0.01)



 Adjusted net income per diluted common share              $
 
   0.75                             to       $
 
    0.85





 
            NM - not meaningful.



 
            Certain amounts may not add due to rounding.

View original content to download multimedia:https://www.prnewswire.com/news-releases/flowers-foods-inc-reports-second-quarter-2026-results-302856673.html

SOURCE Flowers Foods, Inc.

Contact:

Investor Contact: Tim Perrott, InvestorRelations@flocorp.com, Media Contact: http://flowersfoods.com/contact/

© 2026 Canjex Publishing Ltd. All rights reserved.